Below are the most recent publications written about "Biological Products" by people in Profiles.
-
Lou J, Ryan R, Wang D. Biologic Therapies for Discogenic Pain. Curr Pain Headache Rep. 2025 Feb 11; 29(1):45.
-
Welsh JP, Altern SH, Lyall JY, Burgess S, Rauscher MA, Lenhoff AM, Cramer SM, Williams C. Coupling high-throughput and modeling approaches to streamline early-stage process development for biologics. Biotechnol Prog. 2025 May-Jun; 41(3):e3523.
-
Cao Q, Guan J, Li D, Zhang J, Togashi R, Johnson EJ, Chan W, Guo J, Liu P, Liang Y, Cadang L, Mah A, Briggs J, Zhang B, Galvan S, Sadek M, Legg KM, Sen KI, Basanta-Sanchez M, Ruiz LF, Yang F. A Robust and Sensitive New Peak Detection and Identification Method for Mass Spectrometry-Based Differential Analysis in Biologics Characterization. Anal Chem. 2025 01 21; 97(2):1246-1253.
-
Schmoyer CJ, Sun K, Zack J, Kumar P, Shivashankar R. Adverse Events and Compliance Among Inflammatory Bowel Disease Patients Treated With Home- vs Office-Based Biologic Infusions. Inflamm Bowel Dis. 2024 09 03; 30(9):1529-1535.
-
Woods KE, Akhter S, Rodriguez B, Townsend KA, Smith N, Smith B, Wambua A, Craddock V, Abisado-Duque RG, Santa EE, Manson DE, Oakley BR, Hancock LE, Miao Y, Blackwell HE, Chandler JR. Characterization of natural product inhibitors of quorum sensing reveals competitive inhibition of Pseudomonas aeruginosa RhlR by ortho-vanillin. Microbiol Spectr. 2024 09 03; 12(9):e0068124.
-
Godoy-Brewer G, Salem G, Limketkai B, Selaru FM, Grossen A, Policarpo T, Haq Z, Parian AM. Use of Biologics for the Treatment of Inflammatory Conditions of the Pouch: A Systematic Review. J Clin Gastroenterol. 2024 02 01; 58(2):183-194.
-
Sherban A, Brockmeyer K, Cross D, Keller M. Quality of Life in Dermatology Patients on Anti-Cytokine Biologics during the COVID-19 Pandemic. Skinmed. 2023; 21(4):294-298.
-
Dal?n J, Svedbom A, Hernlund E, Olofsson T, Black CM. Identifying Predictors of First-Line Subcutaneous TNF-Inhibitor Persistence in Patients with Inflammatory Arthritis: A Decision Tree Analysis by Indication. Adv Ther. 2023 10; 40(10):4657-4674.
-
Garvey E, Naimi B, Duffy A, Hannikainen P, Kahn C, Farquhar D, Rosen M, Rabinowitz M, Toskala E, Nyquist G. Optimizing the timing of biologic and surgical therapy for patients with refractory chronic rhinosinusitis with nasal polyposis (CRSwNP). Int Forum Allergy Rhinol. 2024 03; 14(3):651-659.
-
Reddy JV, Raudenbush K, Papoutsakis ET, Ierapetritou M. Cell-culture process optimization via model-based predictions of metabolism and protein glycosylation. Biotechnol Adv. 2023 10; 67:108179.